[go: up one dir, main page]

AU2003271457A8 - Methods for detecting prostate cancer - Google Patents

Methods for detecting prostate cancer

Info

Publication number
AU2003271457A8
AU2003271457A8 AU2003271457A AU2003271457A AU2003271457A8 AU 2003271457 A8 AU2003271457 A8 AU 2003271457A8 AU 2003271457 A AU2003271457 A AU 2003271457A AU 2003271457 A AU2003271457 A AU 2003271457A AU 2003271457 A8 AU2003271457 A8 AU 2003271457A8
Authority
AU
Australia
Prior art keywords
methods
prostate cancer
detecting prostate
detecting
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003271457A
Other versions
AU2003271457A1 (en
Inventor
Eleftherios P Diamandis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mt Sinai Hospital
Original Assignee
Mt Sinai Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mt Sinai Hospital filed Critical Mt Sinai Hospital
Publication of AU2003271457A1 publication Critical patent/AU2003271457A1/en
Publication of AU2003271457A8 publication Critical patent/AU2003271457A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003271457A 2002-09-26 2003-09-26 Methods for detecting prostate cancer Abandoned AU2003271457A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41431402P 2002-09-26 2002-09-26
US60/414,314 2002-09-26
PCT/CA2003/001479 WO2004029616A2 (en) 2002-09-26 2003-09-26 Methods for detecting prostate cancer

Publications (2)

Publication Number Publication Date
AU2003271457A1 AU2003271457A1 (en) 2004-04-19
AU2003271457A8 true AU2003271457A8 (en) 2004-04-19

Family

ID=32043380

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003271457A Abandoned AU2003271457A1 (en) 2002-09-26 2003-09-26 Methods for detecting prostate cancer

Country Status (4)

Country Link
EP (1) EP1546729A2 (en)
AU (1) AU2003271457A1 (en)
CA (1) CA2498147A1 (en)
WO (1) WO2004029616A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013359398B2 (en) 2012-12-11 2019-08-15 Cornell University Methods for diagnosing and treating prostate cancer
CN113866412B (en) * 2021-09-07 2024-07-26 山东博科生物产业有限公司 Sensitive total prostate specific antigen detection kit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002097438A1 (en) * 2001-05-25 2002-12-05 Mount Sinai Hospital Method of detecting and monitoring prostate and ovarian cancers

Also Published As

Publication number Publication date
AU2003271457A1 (en) 2004-04-19
CA2498147A1 (en) 2004-04-08
WO2004029616A2 (en) 2004-04-08
WO2004029616A3 (en) 2004-07-15
EP1546729A2 (en) 2005-06-29

Similar Documents

Publication Publication Date Title
AU2003294205A8 (en) Prostate cancer biomarkers
AU2003294828A8 (en) Specific markers for pancreatic cancer
EP1697497A4 (en) Liver cancer biomarkers
GB0303053D0 (en) Collusion detection
IL179059A0 (en) Method of diagnosing prostate cancer
EP1482970A4 (en) Cancer therapy
EP1664716A4 (en) Biomarkers in cancer
EP1551437A4 (en) Methods and compositions for detecting cancers
AU2003263611A8 (en) Method for diagnosing prostate cancer
GB2408761B (en) Multilateral completion system utilizing an alternative passage
AU2003271456A8 (en) Methods for detecting endocrine cancer
AU2003269618A8 (en) Methods for detecting breast and ovarian cancer
AU2003213960A1 (en) Methods for detecting ovarian cancer
GB0228900D0 (en) Cancer Immunotherapy
AU2003235749A8 (en) Biomarkers for detecting ovarian cancer
AU2003231084A8 (en) Identification of biomarkers for detecting prostate cancer
AU2002307466A1 (en) Method for detecting breast cancer cells
AU2002308522A8 (en) Methods for inhibiting tumor cell proliferation
EP1496923A4 (en) Cancer immunotherapy
AU2003256995A8 (en) Method for identifying cancer risk
AU2003276973A8 (en) Detection methods
AU2003202205A1 (en) Methods for identifying cancer risk
EP1625853A4 (en) Apoptosis inducer for cancer cell
AU2003278211A8 (en) Methods for detection of genetic alterations associated with cancer
AU2003287564A8 (en) Methods of detecting colorectal cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase